GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Spectranetics Corp (NAS:SPNC) » Definitions » Float Percentage Of Total Shares Outstanding

The Spectranetics (The Spectranetics) Float Percentage Of Total Shares Outstanding : 85.23% (As of May. 13, 2024)


View and export this data going back to 1992. Start your Free Trial

What is The Spectranetics Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, The Spectranetics's float shares is 37.54 Mil. The Spectranetics's total shares outstanding is 44.05 Mil. The Spectranetics's float percentage of total shares outstanding is 85.23%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, The Spectranetics's Insider Ownership is 5.76%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, The Spectranetics's Institutional Ownership is 74.46%.


The Spectranetics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

The Spectranetics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=37.54/44.05
=85.23%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Spectranetics (The Spectranetics) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Spectranetics manufactures and sells single-use medical devices used in minimally invasive cardiovascular procedures. The firm operates in the three categories: vascular intervention, lead management, and laser, service, and other. The vascular intervention business contributes the majority of revenue and sells laser and aspiration catheters, balloon catheters, and support catheters. The lead management business sells devices used to remove pacemaker and defibrillator cardiac leads. The laser, service, and other business includes a laser system for cardiovascular procedures. Spectranetics generates the vast majority of its revenue in the United States.
Executives
Todd C Schermerhorn director C/O C.R BARD INC, 730 CENTRAL AVE, MURRAY HILL NJ 07974
R John Fletcher director C/O VYANT BIO, INC., 201 ROUTE 17 NORTH, 2ND FLOOR, RUTHERFORD NJ 07070
William C Jennings director 108 CHERRY HILL DRIVE, BEVERLY MA 01915-1053
B Kristine Johnson director 366 FERNDALE RD S, WAYZATA MN 55391
Scott William Drake director, officer: President, CEO 9965 FEDERAL DRIVE, COLORADO SPRINGS CO 80921
Maria Sainz director C/O ORTHOFIX INTERNATIONAL N. V., 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Shahriar Matin officer: Chief Operating Officer 96 TALAMINE COURT, COLORADO SPRINGS CO 80907
Stacy Powell Mcmahan officer: CFO 1000 CRANBERRY WOODS DRIVE, CRANBERRY TOWNSHIP PA 16066
Anne Melissa Dowling director 9965 FEDERAL DRIVE, COLORADO SPRINGS CO 80921
Jonathan Will Mcguire officer: COO 96 TALAMINE COURT, COLORADO SPRINGS CO 80907
Stephen D Okland officer: Vice President of Sales 96 TALAMINE COURT, COLORADO SPRINGS CO 80907
Martin T Hart director 2401 EAST 2ND AVE., SUITE 250, DENVER CO 80206